American Association for the Study of Liver Diseases (AASLD) — ASTRO Joint Session on the Multidisciplinary Management of Hepatocellular Carcinoma: Guidelines, Practicalities and a Tumor Board - 2020 Annual Meeting

Liver cancer incidence is growing faster than any other cancer in men and women. It is evident that the optimal care of patients with HCC necessitates the involvement of a multidisciplinary team utilizing evidence-based cancer guidelines. The American Association for the Study of Liver Diseases (AASLD) Guidelines for the Treatment of HCC serves as the benchmark synoptic guideline for the best evidence-based management of HCC, with NCCN guidelines for HCC adapted from the AASLD guidelines. In this joint AASLD-ASTRO educational session, attendees will gain an appreciation for the AASLD guidelines on the optimal multidisciplinary management for patients with non-metastatic HCC. For clinical scenarios where the data for optimal liver-directed or surgical therapy is conflicted, attendees will hear from a multidisciplinary panel consisting of interventional radiology, hepatology, surgery and interventional radiology on best approaches, perils and pitfalls. 

This activity is available from February 8, 2021, through 11:59 p.m. Eastern time on February 7, 2024.

This activity was originally recorded at ASTRO’s virtual 2020 Annual Meeting, October 23-28th.

Target Audience

The activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, diagnostic radiologists, specialists, and radiation oncology residents. 

Learning Objectives

    Upon completion of this activity, learners should be able to:

    1. Determine the necessity of a multidisciplinary team in the management of HCC and the expertise each brings to the optimal care of the patient.
    2. Differentiate clinical scenarios where AASLD guidelines have clear recommendations on optimal therapies for the management of HCC.
    Course summary
    Available credit: 
    • 1.25 Certificate of Attendance
      This activity was designated for 1.25 AMA PRA Category 1 Credit™.
    • 1.25 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

    Course opens: 
    02/08/2021
    Course expires: 
    02/07/2024
    Cost:
    $105.00
    Rating: 
    0
    • Nima Nabavizadeh, MD is employed at Oregon Health & Science University and has no financial relationships with a commercial interest. 
    • Scott Naugler, MD is employed at Oregon Health & Science University and has no financial relationships with a commercial interest. 
    • Sravana K. Chennupati, MD is employed at Alta Bates Comprehensive Cancer Center, Sutter Health and has no financial relationships with a commercial interest. 
    • Prasoon Mohan, MD is employed at University of Miami Health System and has no financial relationships with a commercial interest. 
    • Parsia Vagefi, MD is employed at University of Texas, Southwestern and has no financial relationships with a commercial interest. 

    The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

    Disclosure link: 
    Committee Disclosures

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.25 Certificate of Attendance
      This activity was designated for 1.25 AMA PRA Category 1 Credit™.
    • 1.25 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

    Price

    Cost:
    $105.00
    Please login or register to take this course.

    Course Fees:
    ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

    • Nonmember: $105
    • Member: $55

    Policies:
    No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

    Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

    The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.